Open Access
Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer
Anupam Bishayee1,Shamima Ahmed1,Nikoleta Brankov1,Marjorie Perloff1
Cancer Therapeutics and Chemoprevention Group, Department of Pharmaceutical Sciences, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, 4209 State Route 44, Rootstown, OH 44272, USA.
DOI: 10.2741/3730 Volume 16 Issue 3, pp.980-996
Published: 01 January 2011
(This article belongs to the Special Issue Novel strategies for detection, prevention and treatment of cancer)

Breast cancer remains a major cause of death in the United States as well as the rest of the world. In view of the limited treatment options for patients with advanced breast cancer, preventive and novel therapeutic approaches play an important role in combating this disease. The plant-derived triterpenoids, commonly used for medicinal purposes in many Asian countries, posses various pharmacological properties. A large number of triterpenoids are known to exhibit cytotoxicity against a variety of tumor cells as well as anticancer efficacy in preclinical animal models. Numerous triterpenoids have been synthesized by structural modification of natural compounds. Some of these analogs are considered to be the most potent antiinflammatory and anticarcinogenic triterpenoids known. This review examines the potential role of natural triterpenoids and their derivatives in the chemoprevention and treatment of mammary tumors. Both in vitro and in vivo effects of these agents and related molecular mechanisms are presented. Potential challenges and future directions involved in the advancement of these promising compounds in the prevention and therapy of human breast cancer are also identified.

Share and Cite
Anupam Bishayee, Shamima Ahmed, Nikoleta Brankov, Marjorie Perloff. Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Frontiers in Bioscience-Landmark. 2011. 16(3); 980-996.